NBP — NovaBridge Biosciences Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for NovaBridge Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	R2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	fx Final	Final	Final	Final	Final
Net Income/Starting Line	-361	-371	-208	-22.2	-88.3
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	147	185	61.9	-55.4	50.6
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	61.2	17.1	-37.1	-2.81	17.1
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	-151	-166	-182	-80.2	-20.6
Capital Expenditures	-4.64	-2.09	-0.164	-0.048	-0.007
Purchase of Fixed Assets
Other Investing Cash Flow Items	-108	70.1	11.1	-158	105
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-113	68	10.9	-158	105
Financing Cash Flow Items	-21.5	2.81	9.91	-4.17	-4.19
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	92.1	6.72	1.67	-4.51	57.7
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-191	-77.3	-165	-242	142